Purple Biotech Ltd. (PPBT)
0.924
-0.09
(-8.51%)
USD |
NASDAQ |
Oct 27, 16:00
0.9389
+0.01
(+1.61%)
After-Hours: 20:00
Purple Biotech Enterprise Value : -4.534M for Oct. 27, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 27, 2026 | -4.534M |
| October 26, 2026 | -4.394M |
| October 23, 2026 | -4.281M |
| October 22, 2026 | -4.330M |
| October 21, 2026 | -4.168M |
| October 20, 2026 | -4.273M |
| October 19, 2026 | -4.281M |
| October 16, 2026 | -4.184M |
| October 15, 2026 | -4.038M |
| October 14, 2026 | -4.038M |
| October 13, 2026 | -3.828M |
| October 12, 2026 | -3.796M |
| October 09, 2026 | -3.877M |
| October 08, 2026 | -3.699M |
| October 07, 2026 | -3.666M |
| October 06, 2026 | -3.650M |
| October 05, 2026 | -3.504M |
| October 02, 2026 | -3.585M |
| October 01, 2026 | -3.569M |
| September 30, 2026 | -3.569M |
| September 29, 2026 | -3.569M |
| September 28, 2026 | -3.618M |
| September 25, 2026 | -3.585M |
| September 24, 2026 | -3.634M |
| September 23, 2026 | -3.626M |
| Date | Value |
|---|---|
| September 22, 2026 | -3.666M |
| September 21, 2026 | -3.715M |
| September 18, 2026 | -3.699M |
| September 17, 2026 | -3.529M |
| September 16, 2026 | -3.553M |
| September 15, 2026 | -3.246M |
| September 14, 2026 | -3.181M |
| September 11, 2026 | -3.246M |
| September 10, 2026 | -3.213M |
| September 09, 2026 | -3.051M |
| September 08, 2026 | -3.116M |
| September 04, 2026 | -3.197M |
| September 03, 2026 | -2.825M |
| September 02, 2026 | -2.825M |
| September 01, 2026 | -3.343M |
| August 31, 2026 | -3.278M |
| August 28, 2026 | -3.310M |
| August 27, 2026 | -3.343M |
| August 26, 2026 | -3.229M |
| August 25, 2026 | -3.359M |
| August 24, 2026 | -3.504M |
| August 21, 2026 | -3.488M |
| August 20, 2026 | -3.472M |
| August 19, 2026 | -3.456M |
| August 18, 2026 | -3.504M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Teva Pharmaceutical Industries Ltd. | 60.28B |
| RedHill Biopharma Ltd. | -11.14M |
| MediWound Ltd. | 136.22M |
| Sol-Gel Technologies Ltd. | 176.10M |
| PolyPid Ltd. | 112.00M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.4486M |
| Total Expenses (Quarterly) | -0.4486M |
| EPS Diluted (Quarterly) | 0.4069 |
| Earnings Yield | -3.04K% |
| Normalized Earnings Yield | -1520.63 |